Matthew L. Posard

Matthew L. Posard serves as director at Halozyme Therapeutics, Inc. (HALO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$225.5K

Total Sells

5 trades

$7.02M

Net Position

Net Seller

$6.79M

Companies Traded

2

HALO, NAUT

Active Period

Dec 2021 – Oct 2026

6 total trades

Most Recent

Sell HALO

Oct 2, 2026 · $567.7K

Matthew L. Posard's Insider Trading at Halozyme Therapeutics, Inc. (HALO)

Buys

0 · $0.00

Sells

5 · $7.02M

Total Shares Bought

0

Total Shares Sold

104,107

HALO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 2, 2026	Sell	5,230	$108.54	$567.7K	58,109
Sep 17, 2026	Sell	18,996	$107.74	$2.05M	74,735
Aug 14, 2024	Sell	29,881	$56.53	$1.69M	89,755
Jun 13, 2024	Sell	20,000	$50.32	$1.01M	109,755
Dec 6, 2022	Sell	30,000	$56.89	$1.71M	125,189

Matthew L. Posard's Insider Trading at Nautilus Biotechnology, Inc. (NAUT)

Buys

1 · $225.5K

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

0

NAUT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 1, 2021	Buy	50,000	$4.51	$225.5K	50,000

Related Insiders

Helen Torley

PRESIDENT AND CEO

HALOSell · Oct 8, 2026

Bernadette Connaughton

Director

HALOSell · Aug 11, 2026

Mahesh Krishnan

director

HALOSell · Jun 30, 2026

AH Equity Partners Bio II, L.L.C.

10 percent owner

NAUTSell · Jun 4, 2026

Cortney Caudill

officer: SVP, CHIEF OPERATING OFFICER

HALOSell · Mar 10, 2026

Nicole LaBrosse

SVP, CHIEF FINANCIAL OFFICER

HALOSell · Feb 16, 2026

Mark Howard Snyder

SVP, CHIEF LEGAL OFFICER

HALOSell · Feb 16, 2026

Explore More Insider Trading Data

HALO Insider Trading Activity

View all insider trades at Halozyme Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity